Meet with us at
June 20 - 22, 2023
Returning for the 12th Annual Year, the Process Development for Highly Potent Drugs Summit: 12th HPAPI will provide benchmarking, clarity, and innovations, for the safe, cost efficient and quality development of hazardous materials in pharma and biotech.
The summit will bring together 100+ process scientists, chemists, engineers, and industrial hygienists from lab scale development to clinical and commercial manufacturing across hazardous small molecules and biologic-based therapeutics.
Stop by Curia's Booth #1
Brian P. Haney received his bachelor of science in chemistry from Allegheny College in Meadville, PA, and then went on to receive a Ph.D. in Chemistry from the University of Pittsburgh. Brian joined AMRI in 2000 as a process chemist and rose through the department to become a group leader. In 2008, he moved to the Rensselaer, NY, facility as a manufacturing manager focusing on HPAPI programs. In 2016, Brian joined AMRI’s global technical operations team with responsibility for project management, commercial technical support, new business evaluation, and product rationalization across an API network of nine international sites
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.
To learn more visit us at curiaglobal.com
220 S 17th Street, Philadelphia, PA, 19103
Be the conduit that connects ideas to solutions. Contribute to the creation and distribution of treatments that enhance and save lives. Ensure that medicines are more accessible and help breakthroughs break through faster. The impact is real at Curia (formerly Albany Molecular Research, Inc.), and you can help us take it to even greater heights.
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.